The 7 major gout markets reached a value of US$ 1.9 Billion in 2023. Looking forward, the publisher expects the 7MM to reach US$ 5.7 Billion by 2034, exhibiting a growth rate (CAGR) of 12.98% during 2023-2034.
The gout market has been comprehensively analyzed in this report titled "Gout Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Gout refers to a form of arthritis in which uric acid crystals build up in the joints, causing inflammation, pain, and swelling. Uric acid is a natural waste material that is produced by the body as it breaks down purines, which are found in various food items and beverages. Gout attacks typically occur suddenly and can be extremely painful. The most common joint affected by this ailment is the big toe; however, it can also occur in other joints, such as the knee, ankle, wrist, and fingers. Individuals suffering from this condition may experience intense joint pain, inflammation, redness, lingering discomfort, limited range of motion, etc. The diagnosis of gout depends on identifying the patient's clinical features, medical history, and physical exam. The healthcare provider may perform a dual-energy computerized tomography test that combines various X-ray images to visualize urate crystals in joints. Numerous other studies used to diagnose this disease include joint fluid tests, blood workup, ultrasound, etc.
The increasing cases of metabolic syndrome that lead to an elevation in uric acid concentration are primarily driving the gout market. In addition to this, the rising incidences of multiple associated risk factors, including being overweight, having a family history of gout, consuming a diet high in purines, certain medical conditions, etc., are also bolstering the market growth. Furthermore, the widespread adoption of colchicine and nonsteroidal anti-inflammatory drugs to effectively reduce pain, control gout flares, and prevent future attacks in patients, is acting as another significant growth-inducing factor. In line with this, the inflating utilization of uricosurics, like probenecid, for treating a moderate-to-severe disease condition by improving the kidneys' ability to remove uric acid from the body is also creating a positive outlook for the market. Moreover, the escalating application of behavioral modifications, which involve a low purine diet, physical exercise, and decreased intake of alcohol to aid in minimizing the severity of illness, is further augmenting the market growth. Apart from this, the emerging popularity of arthroscopic technique to treat the ailment, since it can remove uric acid in the joints, thereby providing better functional outcomes for patients, is expected to drive the gout market in the coming years.
This report provides an exhaustive analysis of the gout market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for gout and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the gout market in any manner.
The gout market has been comprehensively analyzed in this report titled "Gout Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Gout refers to a form of arthritis in which uric acid crystals build up in the joints, causing inflammation, pain, and swelling. Uric acid is a natural waste material that is produced by the body as it breaks down purines, which are found in various food items and beverages. Gout attacks typically occur suddenly and can be extremely painful. The most common joint affected by this ailment is the big toe; however, it can also occur in other joints, such as the knee, ankle, wrist, and fingers. Individuals suffering from this condition may experience intense joint pain, inflammation, redness, lingering discomfort, limited range of motion, etc. The diagnosis of gout depends on identifying the patient's clinical features, medical history, and physical exam. The healthcare provider may perform a dual-energy computerized tomography test that combines various X-ray images to visualize urate crystals in joints. Numerous other studies used to diagnose this disease include joint fluid tests, blood workup, ultrasound, etc.
The increasing cases of metabolic syndrome that lead to an elevation in uric acid concentration are primarily driving the gout market. In addition to this, the rising incidences of multiple associated risk factors, including being overweight, having a family history of gout, consuming a diet high in purines, certain medical conditions, etc., are also bolstering the market growth. Furthermore, the widespread adoption of colchicine and nonsteroidal anti-inflammatory drugs to effectively reduce pain, control gout flares, and prevent future attacks in patients, is acting as another significant growth-inducing factor. In line with this, the inflating utilization of uricosurics, like probenecid, for treating a moderate-to-severe disease condition by improving the kidneys' ability to remove uric acid from the body is also creating a positive outlook for the market. Moreover, the escalating application of behavioral modifications, which involve a low purine diet, physical exercise, and decreased intake of alcohol to aid in minimizing the severity of illness, is further augmenting the market growth. Apart from this, the emerging popularity of arthroscopic technique to treat the ailment, since it can remove uric acid in the joints, thereby providing better functional outcomes for patients, is expected to drive the gout market in the coming years.
This report provides an exhaustive analysis of the gout market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for gout and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the gout market in any manner.
Time Period of the Study
- Base Year: 2023
- Historical Period: 2018-2023
- Market Forecast: 2024-2034
Countries Covered
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the gout market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the gout market
Competitive Landscape:
This report also provides a detailed analysis of the current gout marketed drugs and late-stage pipeline drugs.In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Key Questions Answered in this Report:
Market Insights
- How has the gout market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
- What was the country-wise size of the gout market across the seven major markets in 2023 and what will it look like in 2034?
- What is the growth rate of the gout market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
Epidemiology Insights
- What is the number of prevalent cases (2018-2034) of gout across the seven major markets?
- What is the number of prevalent cases (2018-2034) of gout by age across the seven major markets?
- What is the number of prevalent cases (2018-2034) of gout by gender across the seven major markets?
- How many patients are diagnosed (2018-2034) with gout across the seven major markets?
- What is the size of the gout patient pool (2018-2023) across the seven major markets?
- What would be the forecasted patient pool (2024-2034) across the seven major markets?
- What are the key factors driving the epidemiological trend of gout?
- What will be the growth rate of patients across the seven major markets?
Gout: Current Treatment Scenario, Marketed Drugs and Emerging Therapies
- What are the current marketed drugs and what are their market performance?
- What are the key pipeline drugs and how are they expected to perform in the coming years?
- How safe are the current marketed drugs and what are their efficacies?
- How safe are the late-stage pipeline drugs and what are their efficacies?
- What are the current treatment guidelines for gout drugs across the seven major markets?
- Who are the key companies in the market and what are their market shares?
- What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the gout market?
- What are the key regulatory events related to the gout market?
- What is the structure of clinical trial landscape by status related to the gout market?
- What is the structure of clinical trial landscape by phase related to the gout market?
- What is the structure of clinical trial landscape by route of administration related to the gout market?
Table of Contents
?1 Preface3 Executive Summary6 Patient Journey9 Gout - Unmet Needs10 Gout - Key Endpoints of Treatment13. Gout - Attribute Analysis of Key Marketed and Pipeline Drugs16 Gout - Recent Events and Inputs From Key Opinion Leaders18 Gout Market - Strategic Recommendations19 Appendix
2 Scope and Methodology
4 Gout - Introduction
5 Gout - Disease Overview
7 Gout - Epidemiology and Patient Population
8 Gout - Treatment Algorithm, Guidelines, and Medical Practices
11 Gout - Marketed Products
12 Gout - Pipeline Drugs
14. Gout - Clinical Trial Landscape
15 Gout - Market Scenario
17 Gout Market - SWOT Analysis
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 133 |
| Published | May 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 1.9 Billion |
| Forecasted Market Value ( USD | $ 5.7 Billion |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
